Psyence Biomedical Ltd. Files Form 6-K
Ticker: PBMWW · Form: 6-K · Filed: May 6, 2025 · CIK: 1985062
Sentiment: neutral
Topics: regulatory-filing, press-release
TL;DR
Psyence Biomedical filed a 6-K on May 6th, mostly a press release. CEO Neil Maresky signed off.
AI Summary
Psyence Biomedical Ltd. filed a Form 6-K on May 6, 2025, reporting information for the month of May 2025. The filing includes a press release as Exhibit 99.1. The company is incorporated in A6 and its fiscal year ends on March 31. Dr. Neil Maresky, CEO and Director, signed the report.
Why It Matters
This filing provides an update on Psyence Biomedical Ltd.'s regulatory reporting, indicating ongoing operations and compliance for the period ending May 2025.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily contains a press release and does not disclose significant new financial or operational risks.
Key Players & Entities
- Psyence Biomedical Ltd. (company) — Registrant
- Neil Maresky (person) — Chief Executive Officer and Director
- May 6, 2025 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have filed or are required to file with a stock exchange on which their securities are traded.
What is the SIC code for Psyence Biomedical Ltd.?
The Standard Industrial Classification (SIC) code for Psyence Biomedical Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Where is Psyence Biomedical Ltd. headquartered?
Psyence Biomedical Ltd. is headquartered in Toronto, Ontario, Canada, with its principal executive offices located at 121 Richmond Street West Penthouse Suite 1300, Toronto, Ontario M5H 2K1.
Who signed the Form 6-K filing on behalf of Psyence Biomedical Ltd.?
The Form 6-K was signed by Dr. Neil Maresky, Chief Executive Officer and Director of Psyence Biomedical Ltd.
What exhibits are included in this Form 6-K filing?
This Form 6-K filing includes Exhibit 99.1, which is a Press Release.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 6, 2025 by Neil Maresky regarding PSYENCE BIOMEDICAL LTD. (PBMWW).